Ladenburg Thalmann Upgrades Acrivon Therapeutics Inc (ACRV) to Buy, 'Impressive Endometrial Responses'

September 16, 2024 6:39 AM EDT Send to a Friend
(Updated - September 16, 2024 6:46 AM EDT)

Ladenburg Thalmann analyst Aydin Huseynov upgraded Acrivon Therapeutics Inc (NASDAQ: ACRV) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login